Navigation Links
NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract infection, UTI.

In experiments performed at the Karolinska University Hospital in Sweden, researchers showed that technology developed by NOLabs AB proved to have a high effectiveness in killing pathogens, typically for those causing UTI including an aggressive strain of E. coli. Millions of patients annually acquire UTI while being hospitalized for treatment of other diseases. Preventing such infection has the potential to dramatically reduce the amount of antibiotics used as well as improving quality of life for a large number of hospitalized patients.

Goran Beijer, CEO of NOLabs says; "We are happy to have taken another important step in developing products that have a huge potential to prevent millions of UTI cases globally every year. The anti-microbial effect of NO will be essential in a range of innovative products that prevent and/or treat infection. We expect to have the first products on the market in early 2009."

Professor Peter Wiklund, Karolinska University says; "This new technology has a huge potential to reduce the usage of Antibiotics and thereby the risk of antibiotic resistance as well as reducing the risk of urosepsis, the severest and potentially lethal consequence of UTI."

NOLabs is developing products that will prevent catheter related urinary tract infections, products that will be effective on reducing neuropathic pain and wound care products with an anti-bacterial effect.

NOLabs is a Swedish bio-medtech company focusing on the development and marketing of Nitric Oxide-containing medical devices for various medical applications. Nitric Oxide is a natural substance, produced by the human body controlling vaso-regulation and as part of its protection against pathogens. In particular, NOLabs focuses on developing effective Nitric Oxide based products and therapies that prevent infection and provide pain relief for millions of patients suffering from diabetes-related complications such as chronic wounds and neuropathic pain. Another focus area is the prevention and treatment of urinary tract infections. NOLabs has developed innovative, cost efficient and highly effective technologies that have a significant potential to address serious health issues that impact the lives of over 100 million people.

Goran Beijer


Phone: +46-706-636-009

Susanne Goransson

Phone: +46-42-33-65-21

Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... Research and Markets ( ) has ... Market by Type (Dressings, Therapy Devices, Active Wound Care), ... Facility), and Geography - Global Forecast to 2020" ... --> The purpose of this report ... the global advanced wound care market. It involves deep ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... and prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, ... and helped advance the healthcare industry as a whole through their advocacy and ...
(Date:11/26/2015)... Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... shopping strategy. Many customers choose to buy during the Black Friday and Cyber ... gifts. Shoppers don’t need to search the Internet high and low to find the ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their record books ... their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for the PRMA ... rebuild lives and it’s an honor to have served all of these women.” , ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
Breaking Medicine News(10 mins):